Update on the treatment of peripheral arthritis in psoriatic arthritis.

Abstract:

:Psoriatic arthritis is a chronic, disabling disease for which therapies have been borrowed from rheumatoid arthritis and spondylitis. Traditional disease-modifying antirheumatic drugs (DMARDs) remain the first choice for the treatment of peripheral arthritis despite scarce evidence of their efficacy or ability to halt radiographic progression. Tumor necrosis factor antagonists have the greatest level of evidence for symptom control and radiographic progression. They are currently used after the failure of DMARDs to effectively treat peripheral arthritis, enthesitis, and dactylitis, and are the first choice when axial disease predominates. Despite the use of these treatments, 30% to 40% of patients will still have active disease. Among new drugs, evidence of efficacy has already been published with regard to anti-IL12/23 monoclonal antibody (ustekimumab) and golimumab. Results are forthcoming from trials with certolizumab pegol, abatacept, and rituximab. As knowledge of the pathogenesis of psoriatic arthritis evolves and differences among other arthritis conditions become evident, therapies targeting these distinct features are needed.

journal_name

Curr Rheumatol Rep

authors

Soriano ER,Rosa J

doi

10.1007/s11926-009-0038-9

subject

Has Abstract

pub_date

2009-08-01 00:00:00

pages

270-7

issue

4

eissn

1523-3774

issn

1534-6307

journal_volume

11

pub_type

杂志文章
  • New advances in measurement of complement activation: lessons of systemic lupus erythematosus.

    abstract::Activation of the complement system plays a fundamental role in the pathogenesis of systemic lupus erythematosus (SLE). For the past several decades, quantifying this process has focused primarily on determination of serum C3 and C4, although the utility of these assays for diagnosis and monitoring disease activity is...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-004-0012-5

    authors: Liu CC,Manzi S,Danchenko N,Ahearn JM

    更新日期:2004-10-01 00:00:00

  • Hypocomplementemic urticarial vasculitis syndrome.

    abstract::Hypocomplementemic urticarial vasculitis syndrome (HUVS) is an uncommon immune complex-mediated entity characterized by urticaria with persistent acquired hypocomplementemia. First described in 1973, HUVS is associated with several systemic findings including leukocytoclastic vasculitis, severe angioedema, laryngeal e...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-009-0060-y

    authors: Jara LJ,Navarro C,Medina G,Vera-Lastra O,Saavedra MA

    更新日期:2009-12-01 00:00:00

  • Renal urate handling: clinical relevance of recent advances.

    abstract::Urate is the major inert end product of purine degradation in higher primates in contrast to most other mammals because of the genetic silencing of hepatic oxidative enzyme uricase. The kidney plays a dominant role in urate elimination. The kidney excretes 70% of the daily urate production. Therefore, it is important ...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-996-0044-0

    authors: Anzai N,Enomoto A,Endou H

    更新日期:2005-06-01 00:00:00

  • Rheumatoid arthritis genetics: 2009 update.

    abstract::Recent human genetic discoveries have increased our understanding of rheumatoid arthritis (RA) susceptibility. Genome-wide association studies have expanded the number of validated RA risk loci beyond HLA-DRB1 "shared epitope" alleles to include additional major histocompatibility complex (MHC) risk alleles and more t...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-009-0050-0

    authors: Plenge RM

    更新日期:2009-10-01 00:00:00

  • Takayasu's arteritis.

    abstract::The frequency of Takayasu's arteritis (TA) has been estimated to be 2.9 cases per 1 million people, with a female preponderance, although female-to-male ratio varies from different geographic areas. A high frequency of haplotype A24-B52-DR2 has been found in Japanese patients, without this association in other populat...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-002-0021-1

    authors: Fraga A,Medina F

    更新日期:2002-02-01 00:00:00

  • The scleroderma kidney: progress in risk factors, therapy, and prevention.

    abstract::Scleroderma renal crisis (SRC) is characterized by malignant hypertension, oliguric/anuric acute renal failure, and important mortality, with a 5-year survival rate of 65%. SRC occurs in 2% to 5% of patients with systemic sclerosis (SSc), particularly those with diffuse cutaneous SSc in the first years of disease evol...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-010-0145-7

    authors: Bussone G,Bérezné A,Pestre V,Guillevin L,Mouthon L

    更新日期:2011-02-01 00:00:00

  • How Can We Improve Disease Education in People with Gout?

    abstract:PURPOSE OF REVIEW:Gout management is currently suboptimal despite excellent available therapy. Gout patient education has been shown to enhance medication adherence and self-management, but needs improvement. We explored the literature on gout patient education including gaps in gout patient knowledge; use of written m...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-018-0720-x

    authors: Fields TR,Batterman A

    更新日期:2018-03-08 00:00:00

  • Macrophages in Systemic Sclerosis: Novel Insights and Therapeutic Implications.

    abstract:PURPOSE OF REVIEW:Macrophages play key roles in tissue homeostasis and immune surveillance, mobilizing immune activation in response to microbial invasion and promoting wound healing to repair damaged tissue. However, failure to resolve macrophage activation can lead to chronic inflammation and fibrosis, and ultimately...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-019-0831-z

    authors: Toledo DM,Pioli PA

    更新日期:2019-05-23 00:00:00

  • Consensus procedures and their role in pediatric rheumatology.

    abstract::The Delphi Technique and Nominal Group Technique are two well-recognized consensus-formation methodologies specifically designed to combine judgments from a group of experts. The Delphi Technique utilizes a series of well-defined questionnaire-based surveys, whereas Nominal Group Technique is a structured face-to-face...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-008-0025-6

    authors: Ruperto N,Meiorin S,Iusan SM,Ravelli A,Pistorio A,Martini A

    更新日期:2008-04-01 00:00:00

  • Current Perspectives on Arthroplasty in Systemic Lupus Erythematosus: Rates, Outcomes, and Adverse Events.

    abstract::Systemic lupus erythematosus (SLE) is a chronic debilitating condition with significant impact on the musculoskeletal system. Arthroplasty may be indicated for damage related to active lupus or its treatment. As therapies for SLE have advanced, morbidity and mortality have declined, while the rate of joint replacement...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-016-0608-6

    authors: Kasturi S,Goodman S

    更新日期:2016-09-01 00:00:00

  • Novel Insights into Osteoarthritis Joint Pathology from Studies in Mice.

    abstract::Osteoarthritis causes tremendous individual suffering and staggering societal costs, but due to our limited understanding of the underlying molecular and cellular mechanisms, our avenues for treating this disease are very restricted. Recent years have seen a drastic increase in the use of genetically modified mice to ...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-015-0524-1

    authors: Moon PM,Beier F

    更新日期:2015-08-01 00:00:00

  • New Trials in Lupus and where Are we Going.

    abstract:PURPOSE OF REVIEW:To review progress in the field of clinical trials for SLE. RECENT FINDINGS:Treatment development for SLE has been marked by failures of many later phase studies, representing billions of dollars of lost research and development funding. Recently, more successful Phase II trials have tested reduction...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-018-0745-1

    authors: Thanou A,Merrill JT

    更新日期:2018-05-03 00:00:00

  • Novel therapeutic strategies in scleroderma.

    abstract::Optimal management for scleroderma (systemic sclerosis) is likely to require treatment of the underlying disease process, which remains incompletely understood, and also of the organ-based complications of this heterogeneous condition. Clinical trials evaluating several potential agents have been completed recently, i...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-999-0020-6

    authors: Denton CP,Black CM

    更新日期:1999-10-01 00:00:00

  • Economic Theory and Self-Reported Measures of Presenteeism in Musculoskeletal Disease.

    abstract::This study had two objectives: to describe the historical development of self-reported presenteeism instruments that can be used to identify and measure presenteeism as a result of musculoskeletal disease (MSD) and to identify if, and how many of these, presenteeism instruments are underpinned by economic theory. Syst...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-016-0600-1

    authors: Jones C,Payne K,Gannon B,Verstappen S

    更新日期:2016-08-01 00:00:00

  • Update on biomarkers in psoriatic arthritis.

    abstract::Biomarkers in psoriatic arthritis (PsA) may serve as surrogate end points for disease outcome and can provide insights into disease susceptibility and natural history. Biomarkers could relate to diagnosis, pathogenesis, prognosis, therapeutic response, and comorbidities. The "felt need" is, however, in the development...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-010-0107-0

    authors: Chandran V,Gladman DD

    更新日期:2010-08-01 00:00:00

  • Are spondyloarthropathies as common as rheumatoid arthritis worldwide? A review.

    abstract::The high-range estimate of 1.3% by the National Arthritis Data Workgroup for the prevalence of the entire spectrum of spondyloarthropathies (SpAs) suggests that SpAs may be more prevalent than rheumatoid arthritis (RA) in the United States. Recent surveys from many European countries using the same sample population h...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-008-0060-3

    authors: Akkoc N

    更新日期:2008-10-01 00:00:00

  • Bone health and systemic lupus erythematosus.

    abstract::Osteoporosis is a potentially preventable condition frequently encountered in patients with systemic lupus erythematosus (SLE). Bone loss in SLE is likely a multi- factorial process involving traditional osteoporosis risk factors along with lupus-related factors. Recognizing potential contributors to bone loss in pati...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-005-0056-1

    authors: Lee C,Ramsey-Goldman R

    更新日期:2005-12-01 00:00:00

  • PET Scan: Nuclear Medicine Imaging in Myositis.

    abstract:PURPOSE OF REVIEW:Positron emission tomography (PET) combined with computed tomography (CT) has proven useful as a cancer screening technique in patients with inflammatory myopathy, mainly dermatomyositis. In this review, we focus on advances in this direction and other potential applications of PET/CT in patients with...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-019-0864-3

    authors: Selva-O'Callaghan A,Gil-Vila A,Simó-Perdigó M,Trallero-Araguás E,Alvarado-Cárdenas M,Pinal-Fernandez I

    更新日期:2019-11-21 00:00:00

  • Autoimmune mechanisms in children with systemic lupus erythematosus.

    abstract::Although the pathogenesis of SLE remains poorly understood, there is consensus that it involves a combination of genetic, hormonal, and environmental factors. New technologies applied to genomic and gene expression studies have revealed novel gene mutations and cytokine alterations in this disease. Recently, advances ...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-005-0045-4

    authors: Stichweh D,Pascual V

    更新日期:2005-12-01 00:00:00

  • Biologic therapies in rheumatoid arthritis.

    abstract::Our growing understanding of the immune response mechanism has created a wave of novel biologic agents for the treatment of rheumatoid arthritis. The domain of biologic agents includes: 1) Recombinant regulatory cytokines; 2) engineered molecules and monoclonal antibodies that target proinflammatory cytokines; 3) mono...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-999-0013-5

    authors: Bulpitt KJ

    更新日期:1999-12-01 00:00:00

  • HFE-related hemochromatosis: an update for the rheumatologist.

    abstract::Hereditary hemochromatosis is a frequent disease in Caucasian populations. It leads to progressive iron overload in a variety of organs. The most common cause is the C282Y homozygous mutation in the HFE gene. The classical triad of skin hyperpigmentation, diabetes, and liver cirrhosis is nowadays rare but musculoskele...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-013-0393-4

    authors: Husar-Memmer E,Stadlmayr A,Datz C,Zwerina J

    更新日期:2014-01-01 00:00:00

  • Advances in musculoskeletal imaging and their clinical utility in the early diagnosis of spondyloarthritis.

    abstract::Interest in imaging ankylosing spondylitis (AS) and related spondyloarthropathies has increased in recent years. MRI is regarded as the most sensitive imaging modality to detect early inflammatory lesions in the sacroiliac joints and in the spine. Standard radiography plays a major role in evaluating potential disease...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-007-0057-3

    authors: Weber U,Kissling RO,Hodler J

    更新日期:2007-10-01 00:00:00

  • Neonatal lupus: clinical features, therapy, and pathogenesis.

    abstract::Neonatal lupus is a disease characterized by one or more of the following findings: congenital heart block, cardiomyopathy, cutaneous lupus lesions, hepatobiliary disease, and thrombocytopenia. Accumulating evidence indicates that the disease is probably caused by maternal autoantibodies, particularly autoantibodies o...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-996-0009-3

    authors: Lee LA

    更新日期:2001-10-01 00:00:00

  • The microbiome and psoriatic arthritis.

    abstract::Psoriatic arthritis is a chronic inflammatory joint disease, seen in combination with the chronic inflammatory skin disease psoriasis and belonging to the family of spondylarthritides (SpA). A link is recognized between psoriatic arthritis and inflammatory bowel disease (IBD). Environmental factors seem to induce infl...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-013-0407-2

    authors: Eppinga H,Konstantinov SR,Peppelenbosch MP,Thio HB

    更新日期:2014-03-01 00:00:00

  • Tumor-Induced Osteomalacia: an Up-to-Date Review.

    abstract::Tumor-induced osteomalacia (TIO) is a paraneoplastic syndrome resulting in renal phosphate wasting and decreased bone mineralization. TIO is usually induced by small, slowly growing tumors of mesenchymal origin (phosphaturic mesenchymal tumor mixed connective tissue variant [PMTMCT]). Nonspecific symptoms including fa...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-015-0512-5

    authors: Hautmann AH,Hautmann MG,Kölbl O,Herr W,Fleck M

    更新日期:2015-06-01 00:00:00

  • Control of connective tissue gene expression by TGF beta: role of Smad proteins in fibrosis.

    abstract::Transforming growth factor-beta (TGF beta) plays a critical role in the development of tissue fibrosis. Its expression is consistently elevated in affected organs and correlates with increased extracellular matrix deposition. During the last few years, tremendous progress has been made in understanding the molecular a...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-002-0010-4

    authors: Verrecchia F,Mauviel A

    更新日期:2002-04-01 00:00:00

  • Rheumatoid Arthritis Pharmacotherapies: Do They Have Anti-Atherosclerotic Activity?

    abstract::Rheumatoid arthritis (RA) is associated with a heightened risk of cardiovascular disease (CVD) events, presumably related to a greater burden of atherosclerosis, as well as atherosclerotic plaques that tend to be inflamed and rupture prone. Many of the inflammatory pathways underlying the pathobiology of RA are also r...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-016-0578-8

    authors: Giles JT

    更新日期:2016-05-01 00:00:00

  • Imaging osteoarthritis: magnetic resonance imaging versus x-ray.

    abstract::Until recently, imaging evaluation of osteoarthritis has relied primarily on conventional radiography. Using radiography in clinical practice or clinical research, however, has been fraught with difficulty. Techniques for reproducibly acquiring serial radiographs of joints have improved considerably over the past seve...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-006-0020-8

    authors: Peterfy C,Kothari M

    更新日期:2006-02-01 00:00:00

  • The Changing Face of Clinical Trials in Psoriatic Arthritis.

    abstract:PURPOSE OF THE REVIEW:We will address current treatment and unmet needs in psoriatic arthritis (PsA), examine existing randomized controlled trials (RCTs), and consider options for new trial designs and challenges in their implementation. RECENT FINDINGS:While therapeutic options for PsA have rapidly increased, there ...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-017-0642-z

    authors: Ogdie A,Coates L

    更新日期:2017-04-01 00:00:00

  • Difficult clinical situations in the antiphospholipid syndrome.

    abstract::Antiphospholipid syndrome (APS) is characterized by antiphospholipid antibodies (aPL) associated with thrombosis and/or pregnancy morbidity. However, there is a range of other manifestations associated with APS, called non-criteria manifestations that add significant morbidity to this syndrome and, some of them, repre...

    journal_title:Current rheumatology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11926-015-0502-7

    authors: Rosa RF,Ugolini-Lopes MR,Zeinad-Valim AK,D'Amico E,Andrade D

    更新日期:2015-04-01 00:00:00